Nesek-Adam V, Vnuk D, Rai , Rumenjak V, Kos J, Krstonijevi Z
Metabolic Enhancement: The medication helps in reducing orexin activity, increasing satiety hormone release, and delaying gastric emptying, all of which contribute to fewer hunger signals and effective calorie management
Moreover, pharmacologic treatments cannot reset the circadian clock rhythm
It is thought to improve insulin sensitivity and may stimulate GLP-1 secretion in the gut
diabetes approval anticipated later in 2026 Not yet approved in Canada: but worth knowing about now If you've ever wished the GLP-1 medications that have transformed diabetes care could come in a simple daily pill, without needles, refrigeration, or strict timing around meals, you may be closer to that reality than you think
Sue Pederson, a Calgary endocrinologist, said she heard the tag could fall to a third of the price of the name brand